Brokerages Set Phreesia, Inc. (NYSE:PHR) PT at $20.82

Phreesia, Inc. (NYSE:PHR) has been given an average recommendation of “Moderate Buy” by the nineteen brokerages that are presently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and twelve have issued a buy rating on the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $20.8235.

PHR has been the subject of a number of analyst reports. DA Davidson dropped their price objective on shares of Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a report on Friday, January 23rd. Stephens lowered their target price on shares of Phreesia from $32.00 to $20.00 and set an “overweight” rating for the company in a research note on Tuesday, March 31st. Citigroup reaffirmed a “neutral” rating and set a $10.00 target price (down from $25.00) on shares of Phreesia in a research note on Tuesday, March 31st. Wells Fargo & Company lowered their target price on shares of Phreesia from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, March 26th. Finally, KeyCorp lowered their target price on shares of Phreesia from $15.00 to $12.00 and set an “overweight” rating for the company in a research note on Monday, April 13th.

Phreesia Trading Up 0.5%

Shares of PHR opened at $10.22 on Wednesday. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.41. Phreesia has a 12-month low of $7.77 and a 12-month high of $32.76. The firm has a 50-day moving average price of $10.29 and a 200 day moving average price of $15.06. The firm has a market capitalization of $620.72 million, a P/E ratio of 340.53 and a beta of 0.89.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, March 30th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.05). Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The firm had revenue of $127.07 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same period in the prior year, the company posted ($0.11) EPS. The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. Sell-side analysts forecast that Phreesia will post 0.28 EPS for the current year.

Insider Activity at Phreesia

In other Phreesia news, CFO Balaji Gandhi sold 3,829 shares of the stock in a transaction dated Wednesday, March 25th. The shares were sold at an average price of $11.26, for a total transaction of $43,114.54. Following the completion of the transaction, the chief financial officer owned 146,740 shares of the company’s stock, valued at $1,652,292.40. This trade represents a 2.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Yvonne Hui sold 10,063 shares of the stock in a transaction dated Thursday, April 16th. The stock was sold at an average price of $9.08, for a total transaction of $91,372.04. Following the transaction, the insider directly owned 25,991 shares of the company’s stock, valued at approximately $235,998.28. This trade represents a 27.91% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 50,493 shares of company stock worth $461,983. 5.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of PHR. Federated Hermes Inc. purchased a new position in Phreesia during the third quarter worth about $32,000. Van ECK Associates Corp lifted its position in shares of Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock worth $42,000 after purchasing an additional 1,102 shares in the last quarter. New York State Teachers Retirement System acquired a new stake in shares of Phreesia during the first quarter worth about $44,000. Asset Management One Co. Ltd. acquired a new stake in shares of Phreesia during the third quarter worth about $45,000. Finally, Rockefeller Capital Management L.P. lifted its position in shares of Phreesia by 354.6% during the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after purchasing an additional 2,149 shares in the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.